Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18

被引:204
作者
Kohno, Masashi
Hasegawa, Hitoshi [1 ]
Inoue, Atsushi
Muraoka, Masatake
Miyazaki, Tatsuhiko
Oka, Keizo
Yasukawa, Masaki
机构
[1] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Toon, Ehime 7910295, Japan
[2] Ehime Univ, Grad Sch Med, Dept Pathogenom, Toon, Ehime 7910295, Japan
[3] Integrated Ctr Sci, Toon, Ehime 7910295, Japan
关键词
lymphocytes; G-protein-coupled receptors; lipids; adult T-cell leukemia;
D O I
10.1016/j.bbrc.2006.06.175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An orphan G-protein-coupled receptor, GPR18, was cloned on the basis of degenerate-oligonucleotide PCR analysis of HUT 102 cells using primers designed from the conservative regions of the human chemokine receptor. GPR18 was expressed significantly in lymphoid cell lines, but not in non-lymphoid hematopoietic cell lines. Moreover, the expression of the GPR18 gene was higher in peripheral lymphocyte subsets (CD4(+), CD4(+)CD45RA(+), CD4(+)CD45RO(+), CD8(+), and CD19(+)) than in monocytes and lymphoid cell lines, and was increased after stimulation with phytohemagglutinin. By screening using a lipid library, N-arachidonylglycine (NAGly) induced an increase in intracellular Ca2+ concentration in GPR18-transfected cells, which was significantly greater than that in mock-transfected cells. NAGly also inhibited forskolin-induced cAMP production in a pertussis toxin-sensitive manner in the GPR18-transfected CHO cells. This is the first study to demonstrate that NAGly is a natural ligand for GPR18. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:827 / 832
页数:6
相关论文
共 29 条
[1]   EPSTEIN-BARR VIRUS-INDUCED GENES - 1ST LYMPHOCYTE-SPECIFIC G-PROTEIN-COUPLED PEPTIDE RECEPTORS [J].
BIRKENBACH, M ;
JOSEFSEN, K ;
YALAMANCHILI, R ;
LENOIR, G ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2209-2220
[2]   Regulation of anandamide tissue levels by N-arachidonylglycine [J].
Burstein, SH ;
Huang, SM ;
Petros, TJ ;
Rossetti, RG ;
Walker, JM ;
Zurier, RB .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (07) :1147-1150
[3]   Lipids as bioeffectors in the immune system [J].
Cabral, GA .
LIFE SCIENCES, 2005, 77 (14) :1699-1710
[4]   A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase [J].
Cascio, MG ;
Minassi, A ;
Ligresti, A ;
Appendino, G ;
Burstein, S ;
Di Marzo, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (01) :192-196
[5]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[6]   Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis [J].
Gantz, I ;
Muraoka, A ;
Yang, YK ;
Samuelson, LC ;
Zimmerman, EM ;
Cook, H ;
Yamada, T .
GENOMICS, 1997, 42 (03) :462-466
[7]   Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes [J].
Ghosh, Sharmistha ;
Preet, Anju ;
Groopman, Jerome E. ;
Ganju, Ramesh K. .
MOLECULAR IMMUNOLOGY, 2006, 43 (14) :2169-2179
[8]   Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice [J].
Hasegawa, H ;
Kohno, M ;
Sasaki, M ;
Inoue, A ;
Ito, MR ;
Terada, M ;
Hieshima, K ;
Maruyama, H ;
Miyazaki, JI ;
Yoshie, O ;
Nose, M ;
Fujita, S .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2555-2566
[9]  
Hasegawa H, 2000, BLOOD, V95, P30
[10]   Characterization of the human cysteinyl leukotriene 2 receptor [J].
Heise, CE ;
O'Dowd, BF ;
Figueroa, DJ ;
Sawyer, N ;
Nguyen, T ;
Im, DS ;
Stocco, R ;
Bellefeuille, JN ;
Abramovitz, M ;
Cheng, R ;
Williams, DL ;
Zeng, ZZ ;
Liu, QY ;
Ma, L ;
Clements, MK ;
Coulombe, N ;
Liu, Y ;
Austin, CP ;
George, SR ;
O'Neill, GP ;
Metters, KM ;
Lynch, KR ;
Evans, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30531-30536